Skip to main content

Table 1 Interactions between meat intake and polymorphisms in relation to the risk of colorectal cancer in prospective cohorts

From: Interactions between meat intake and genetic variation in relation to colorectal cancer

Gene

rs-numberd

  

N cases

N sub-cohort

IRR/OR (95 % CI)a

P bint

Commentsc

First author

Year

References

Cooking carcinogens and mutagens

           

NAT1

  

Slow

120

123

  

4

Chen

1998

Chen et al. (1998)

  

NAT*10 allele

Rapid

92

98

 

0.19

4

  

Chen et al. (1998)

NAT2

  

Slow

131

125

  

4

  

Chen et al. (1998)

   

Rapid

81

96

 

0.56

4

  

Chen et al. (1998)

NAT2

  

Slow

107

267

  

5

Chan

2005

Chan et al. (2005)

   

Rapid

76

476

 

0.07

5

  

Chan et al. (2005)

NAT1

  

Slow

  

0.99 (0.94–1.04)

 

2, 3, 6

Sorensen

2008

Sorensen et al. (2008)

   

Fast

  

0.98 (0.90–1.05)

>0.40

2, 3, 6

  

Sorensen et al. (2008)

NAT2

  

Slow

  

1.00 (0.95–1.06)

 

2, 3, 6

  

Sorensen et al. (2008)

   

Fast

  

0.96 (0.90–1.03)

>0.40

2, 3, 6

  

Sorensen et al. (2008)

NAT1

  

No*10

362

527

  

7

Nothlings

2009

Nothlings et al. (2009)

   

*10

482

818

 

0.77

7

  

Nothlings et al. (2009)

NAT2

  

Slow/med

750

1149

  

7

  

Nothlings et al. (2009)

   

Rapid

242

344

 

0.44

7

  

Nothlings et al. (2009)

NAT1

  

No*10

362

527

  

8

  

Nothlings et al. (2009)

   

*10

482

818

 

0.93

8

  

Nothlings et al. (2009)

NAT2

  

Slow/med

750

1,149

  

8

  

Nothlings et al. (2009)

   

Rapid

242

344

 

0.13

8

  

Nothlings et al. (2009)

AHR

rs2066853

  

364

394

 

0.07

12

Gilsing

2012

Gilsing et al. (2012)

UGT1A

rs6714486

  

364

394

 

0.06

12

  

Gilsing et al. (2012)

 

rs17868299

  

364

394

 

0.05

12

  

Gilsing et al. (2012)

UGT1A

rs2011404

  

364

394

 

0.08

12

  

Gilsing et al. (2012)

CYP2E1

rs915908

  

364

394

 

0.05

12

  

Gilsing et al. (2012)

UGT1A

rs6717546

  

364

394

 

0.04

12

  

Gilsing et al. (2012)

UGT1A

rs12466997

  

364

394

 

0.08

12

  

Gilsing et al. (2012)

Arachidonic acid pathway

           

PTGS2 (COX-2)

rs689566

A-1195G

AA–AG

900

1,686

1.02 (0.98–1.05)

 

1, 2, 3

Andersen

2013

Andersen et al. (2013b)

   

GG

47

61

1.06 (0.87–1.29)

0.54

1, 2, 3

  

Andersen et al. (2013b)

 

rs20417

G-765C

GG

701

1,256

0.99 (0.95–1.03)

 

1, 2, 3

  

Andersen et al. (2013b)

   

GC–CC

235

478

1.08 (1.01–1.15)

0.006

1, 2, 3

  

Andersen et al. (2013b)

 

rs5275

T8473C

TT

430

720

1.04 (0.99–1.09)

 

1, 2, 3

  

Andersen et al. (2013b)

   

TC–CC

501

1,018

1.01 (0.96–1.05)

0.29

1, 2, 3

  

Andersen et al. (2013b)

Transport proteins

           

ABCB1 (MDR1)

rs1045642

3435

CC

73

118

1.08 (1.00–1.16)

 

1, 2, 3

Andersen

2009

Andersen et al. (2009)

   

CT–TT

286

647

1.00 (0.95–1.06)

0.02

1, 2, 3

  

Andersen et al. (2009)

 

rs3789243

Intron 3

GG

81

224

0.95 (0.89–1.02)

 

1, 2, 3

  

Andersen et al. (2009)

   

GA–AA

278

541

1.03 (0.98–1.09)

0.01

1, 2, 3

  

Andersen et al. (2009)

ABCG2 (BCRP)

rs2231142

C421A

CC

296

592

1.02 (0.97–1.08)

 

1, 2, 3

  

Andersen et al. (2009)

   

CA–AA

63

173

0.99 (0.91–1.08)

0.40

1, 2, 3

  

Andersen et al. (2009)

ABCC2 (MRP2)

rs717620

C-24T

CC

260

508

1.02 (0.97–1.07)

 

1, 2, 3

Andersen

2012

Andersen et al. (2012b)

   

CT–TT

129

280

1.03 (0.95–1.12)

0.72

1, 2, 3

  

Andersen et al. (2012b)

 

rs2273697

G1249A

GG

238

480

1.05 (0.99–1.11)

 

1, 2, 3

  

Andersen et al. (2012b)

   

AG–AA

151

308

0.98 (0.91–1.05)

0.10

1, 2, 3

  

Andersen et al. (2012b)

 

rs3740066

C3972T

CC

143

301

1.01 (0.96–1.08)

 

1, 2, 3

  

Andersen et al. (2012b)

   

CT–TT

246

487

1.03 (0.97–1.10)

0.69

1, 2, 3

  

Andersen et al. (2012b)

Cytokines

           

IL10

rs1800872

C-592A

CC

238

470

1.02 (0.97–1.07)

 

1, 2, 3, 9

Andersen

2012

Andersen et al. (2012b)

   

AC–AA

140

305

1.02 (0.95–1.11)

0.92

1, 2, 3, 9

  

Andersen et al. (2012b)

 

rs3024505

 

CC

268

553

1.02 (0.96–1.08)

 

1, 2, 3, 9

  

Andersen et al. (2012b)

   

CT–TT

110

222

1.03 (0.96–1.10)

0.78

1, 2, 3, 9

  

Andersen et al. (2012b)

IL10

rs1800872

C-592A

CC

596

1072

1.02 (0.98–1.06)

 

1, 2, 3

Andersen

2013

Andersen et al. (2013b)

   

AC–AA

353

676

1.00 (0.95–1.06)

0.46

1, 2, 3

  

Andersen et al. (2013b)

 

rs3024505

 

CC

648

1,200

1.00 (0.96–1.04)

 

1, 2, 3

  

Andersen et al. (2013b)

   

CT–TT

297

565

1.06 (1.00–1.11)

0.04

1, 2, 3

  

Andersen et al. (2013b)

IL1B

rs4848306

C-3737T

CC

336

560

1.01 (0.96–1.07)

 

1, 2, 3

  

Andersen et al. (2013b)

   

CT–TT

605

1,186

1.02 (0.98–1.06)

0.65

1, 2, 3

  

Andersen et al. (2013b)

 

rs1143623

G-1464C

GG

454

925

1.02 (0.97–1.06)

 

1, 2, 3

  

Andersen et al. (2013b)

   

GC–CC

492

824

1.02 (0.97–1.07)

0.94

1, 2, 3

  

Andersen et al. (2013b)

 

rs1143627

T-31C

TT

389

773

1.00 (0.96–1.05)

 

1, 2, 3

  

Andersen et al. (2013b)

   

TC–CC

557

983

1.03 (0.98–1.07)

0.40

1, 2, 3

  

Andersen et al. (2013b)

Transcription factors

           

NFKB1

rs28362491

−94 ins/del

II

122

307

0.96 (0.90–1.04)

 

1, 2, 3

Andersen

2010

Andersen et al. (2010)

   

ID–DD

261

456

1.03 (0.97–1.08)

0.03

1, 2, 3

  

Andersen et al. (2010)

NR1I2 (PXR)

rs1523127

A-24381C

AA

131

261

1.04 (0.97–1.12)

 

1, 2, 3

  

Andersen et al. (2010)

   

AC–CC

252

502

1.01 (0.95–1.06)

0.20

1, 2, 3

  

Andersen et al. (2010)

 

rs2276707

C8055T

CC

237

448

1.02 (0.96–1.08)

 

1, 2, 3

  

Andersen et al. (2010)

   

CT–TT

146

315

1.01 (0.95–1.08)

0.74

1, 2, 3

  

Andersen et al. (2010)

 

rs6785049

A7635G

AA

137

264

1.01 (0.95–1.07)

 

1, 2, 3

  

Andersen et al. (2010)

   

AG–GG

246

499

1.02 (0.96–1.08)

0.60

1, 2, 3

  

Andersen et al. (2010)

NR1H2 (LXR)

rs1405655

 

CC

40

76

1.01 (0.93–1.10)

 

1, 2, 3

  

Andersen et al. (2010)

   

CT–TT

343

687

1.02 (0.96–1.07)

0.94

1, 2, 3

  

Andersen et al. (2010)

 

rs2695121

 

TT

117

227

1.03 (0.96–1.11)

 

1, 2, 3

  

Andersen et al. (2010)

   

CT–CC

266

536

1.01 (0.96–1.07)

0.43

1, 2, 3

  

Andersen et al. (2010)

Heme oxygenase

          

Andersen et al. (2011a)

HMOX1 (HO-1)

rs2071746

A-413T

AA

118

260

1.00 (0.93–1.08)

 

1, 2, 3

Andersen

2011

Andersen et al. (2011a, b)

   

AT–TT

265

503

1.02 (0.97–1.08)

0.55

1, 2, 3

  

Andersen et al. (2011a, b)

DNA repair

           

MSH3

rs184967

R940Q

RR

127

   

8, 10

Berndt

2007

Berndt et al. (2007)

   

RQ–QQ

65

  

0.08

8, 10

  

Berndt et al. (2007)

MSH3

rs26279

T1036A

TT

85

   

8, 10

  

Berndt et al. (2007)

   

TA–AA

102

  

0.002

8, 10

  

Berndt et al. (2007)

MSH6

rs1042821

G39E

GG

118

   

8, 10

  

Berndt et al. (2007)

   

GE–EE

54

  

0.29

8, 10

  

Berndt et al. (2007)

MLH1

rs1799977

I219V

II

84

   

8, 10

  

Berndt et al. (2007)

   

IV–VV

101

  

0.40

8, 10

  

Berndt et al. (2007)

XPC

Rs2228001d

Lys939Gln

AA

141

307

1.17 (0.71–1.92)

 

7, 11

Hansen

2007

Hansen et al. (2007)

   

AC

204

392

1.11 (0.70–1.75)

 

7, 11

  

Hansen et al. (2007)

   

CC

50

98

3.70 (1.70–8.04)

0.01

7, 11

  

Hansen et al. (2007)

XPA

 

A23G

GG

176

339

1.30 (0.78–2.17)

 

7, 11

  

Hansen et al. (2007)

   

AG

187

359

1.41 (0.87–2.26)

 

7, 11

  

Hansen et al. (2007)

   

AA

31

90

0.76 (0.34–1.66)

0.37

7, 11

  

Hansen et al. (2007)

ERCC2 (XPD)

Rs1799793d

Asp312Asn

GG

159

333

1.25 (0.69–2.26)

 

7, 11

  

Hansen et al. (2007)

   

AG

191

354

1.25 (0.83–1.87)

 

7, 11

  

Hansen et al. (2007)

   

AA

46

108

1.22 (0.61–2.45)

1.00

7, 11

  

Hansen et al. (2007)

XPC

Rs2228001d

Lys939Gln

AA

141

307

0.63 (0.23–1.69)

 

8, 11

  

Hansen et al. (2007)

   

AC

204

392

0.94 (0.41–2.15)

 

8, 11

  

Hansen et al. (2007)

   

CC

50

98

3.78 (0.64–22.29)

0.20

8, 11

  

Hansen et al. (2007)

XPA

 

A23G

GG

176

339

0.58 (0.23–1.48)

 

8, 11

  

Hansen et al. (2007)

   

AG

187

359

1.87 (0.73–4.83)

 

8, 11

  

Hansen et al. (2007)

   

AA

31

90

0.31 (0.06–1.64)

0.06

8, 11

  

Hansen et al. (2007)

ERCC2 (XPD)

Rs1799793d

Asp312Asn

GG

159

333

1.07 (0.38–3.03)

 

8, 11

  

Hansen et al. (2007)

   

AG

191

354

0.75 (0.33–1.68)

 

8, 11

  

Hansen et al. (2007)

   

AA

46

108

1.93 (0.43–8.63)

0.49

8, 11

  

Hansen et al. (2007)

  1. aOdds ratio (OR) or incidence rate ratio (IRR)
  2. b P for interaction (P int) between meat and the genotypes in relation to CRC has been retrieved from the studies and may have been calculated in different ways
  3. cComments: (1) Incidence rate ratio (IRR) for colorectal cancer per intake of 25 g red or processed meat. (2) Adjusted for sex and age, smoking status, alcohol, HRT status (women only), BMI, NSAID use, and dietary fibre. (3) P value for interaction between the genotype and dietary intake for the fully adjusted risk estimate. (4) Tertile analyses of daily red meat intake (≤0.5, >0.5–1, <1). 5) Tertile analyses of intake of beef, pork, or lamb as a main dish (≤0.5, >0.5 servings per day). (6) IRR for colorectal cancer per intake of 25 g red meat. (7) Intake of red meat. (8) Intake of processed meat. (9) These data (Andersen et al. 2012a, b) are also included in (Andersen et al. 2013a, b). (10) Adjusted for age, race, and energy intake. (11) Adjusted for average smoking intensity, intake of alcohol, fruits/vegetable, fish/poultry, red meat, dietary fibres, BMI, and hormone replacement therapy. (12) Interactions between intake of benzo{a]pyrene (B[a]P), 2-amino-3,8-dimethylimidazol[4,5-f]quinoxaline (MeIQx), 2-amino-3,4,8-trimethylimidazol[4,5-f]quinoxaline (DiMeIQx), and combined nitrate and nitrite, respectively, and the polymorphisms
  4. drs number was not provided by the authors. Rs number has been identified and provided as described in the “Methods” section in cases where the rs number could be unambiguously identified